OSI-906: Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906

ARV-771 : BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436